PMC:7781431 / 749-1083
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 33 | 177-204 | Species | denotes | respiratory syncytial virus | Tax:12814 |
| 34 | 206-234 | Species | denotes | human immunodeficiency virus | Tax:12721 |
| 35 | 240-257 | Species | denotes | hepatitis C virus | Tax:11103 |
| 41 | 81-98 | Chemical | denotes | -resolving lipids | |
| 46 | 64-76 | Disease | denotes | inflammation | MESH:D007249 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T3 | 212-228 | Phenotype | denotes | immunodeficiency | http://purl.obolibrary.org/obo/HP_0002721 |
| T4 | 240-249 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 78-258 | Sentence | denotes | Pro-resolving lipids mediators have shown great promise for the treatment of Herpes simplex virus, respiratory syncytial virus, human immunodeficiency virus, and hepatitis C virus. |